TNF and hereditary elliptocytosis: Compared with controls, daily intake of VSL#3 significantly reduced the risk of hospitalization for HE, MELD scores, inflammatory markers like TNF-α, IL-1b, and IL-6, plasma renin, aldosterone, blood ammonia, and indole levels.